Treatment Persistence and Factors Associated with Bimekizumab Discontinuation in Psoriatic Arthritis and Axial Spondyloarthritis: A Real-World Multicenter Study.
- DOI
- 10.3390/biomedicines14081778
- Published
- 2026 Aug 7
- Container
- Biomedicines
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/biomedicines14081778,
title = {Treatment Persistence and Factors Associated with Bimekizumab Discontinuation in Psoriatic Arthritis and Axial Spondyloarthritis: A Real-World Multicenter Study.},
author = {Pinto-Tasende JA and Garcia-Porrua C and Maceiras-Pan F and Melero-González RB and Hernandez Del Rio A and Cervantes Pérez EC and Quevedo-Vila V and Iñiguez CL and Alonso-Castro S and Caeiro-Aguado M and Queiro R},
year = {2026},
journal = {Biomedicines},
doi = {10.3390/biomedicines14081778},
url = {https://doi.org/10.3390/biomedicines14081778}
}RIS
TY - JOUR TI - Treatment Persistence and Factors Associated with Bimekizumab Discontinuation in Psoriatic Arthritis and Axial Spondyloarthritis: A Real-World Multicenter Study. AU - Pinto-Tasende JA AU - Garcia-Porrua C AU - Maceiras-Pan F AU - Melero-González RB AU - Hernandez Del Rio A AU - Cervantes Pérez EC AU - Quevedo-Vila V AU - Iñiguez CL AU - Alonso-Castro S AU - Caeiro-Aguado M AU - Queiro R PY - 2026 JO - Biomedicines DO - 10.3390/biomedicines14081778 UR - https://doi.org/10.3390/biomedicines14081778 ER -
APA
JA, P., C, G., F, M., RB, M., A, H. D. R., EC, C. P., V, Q., CL, I., S, A., M, C., & R, Q. (2026). Treatment Persistence and Factors Associated with Bimekizumab Discontinuation in Psoriatic Arthritis and Axial Spondyloarthritis: A Real-World Multicenter Study.. Biomedicines. https://doi.org/10.3390/biomedicines14081778
Source records
- pubmed · retrieved 2026-09-26T19:01:08.446Z